Please provide your email address to receive an email when new articles are posted on . Subclinical left ventricular abnormalities in SSc impact survival and increase dyspnea risk. LV ejection ...

Background There is a lack of contemporary data describing patients with left ventricular (LV) systolic dysfunction post ...

Please provide your email address to receive an email when new articles are posted on . Key risk factors that may predict severe disease in patients with MIS-C include fever greater than 103.1 degrees ...

Declines in physical function from androgen deprivation therapy (ADT) in men with nonmetastatic prostate cancer: A matched cohort study No significant financial relationships to disclose. This is an ...

BARCELONA, Spain—Coronary revascularization with PCI fails to provide any additional benefit beyond guideline-directed medical therapy (GDMT) in patients with severely impaired left ventricular ...

Patients with severe left ventricular dysfunction undergoing TAVI for aortic stenosis who experience an improvement in their ventricle’s function achieve mid-term mortality similar to that seen among ...

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease ...

Monitoring for Chemotherapy-Related Cardiotoxicity in the Form of Left Ventricular Systolic Dysfunction: A Review of Current Recommendations The following represents disclosure information provided by ...

Left ventricular hypertrophy (LVH) is when the heart’s main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart ...

A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of—and repair ...